Analysts Set Silence Therapeutics plc (NASDAQ:SLN) Target Price at $40.67
Shares of Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and six have issued a buy rating on the company. The average 1-year […]
Shares of Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and six have issued a buy rating on the company. The average 1-year […]
